Key | % Net Assets |
---|---|
UBS | 4.5% |
Novartis | 4.4% |
BNP Paribas | 4.4% |
DnB NOR Bank | 4.0% |
Other | 82.7% |
Name | % Net Assets |
---|---|
UBS | 4.5% |
Novartis | 4.4% |
BNP Paribas | 4.4% |
DnB NOR Bank | 4.0% |
Roche Holding | 3.8% |
Brenntag | 3.5% |
Hexagon | 3.5% |
Assa Abloy | 3.4% |
Svenska Cellulosa | 3.3% |
Henkel | 3.3% |
Key | % Net Assets |
---|---|
Industrials | 20.00% |
Consumer Goods | 18.60% |
Health Care | 17.50% |
Financials | 16.80% |
Basic Materials | 16.50% |
Date | 25-Apr-2024 |
---|---|
NAV | 93.36p |
Currency | GBP |
Change | -1.75p |
% | -1.84% |
YTD change | -4.10p |
YTD % | -4.21% |
Fund Inception | 03/10/2003 |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research